Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOvoca Bio Regulatory News (OVB)

  • There is currently no data for OVB

Management Appointment

24 May 2006 07:00

Ovoca Gold PLC24 May 2006 Wednesday, 24 May 2006 Ovoca management team boosted by appointment of Simon Beardsmore as Commercial Manager Ovoca Gold Plc (AIM: OVG; IEX: OVX) announced today the appointment of Mr SimonBeardsmore as Commercial Manager. Simon, 55, is a graduate of the Royal Schoolof Mines at Imperial College, London and a UK Chartered Engineer with over 30years experience in the operational, technical and financial aspects of miningindustry internationally. He has also undertaken post-graduate work ongeo-statistics at the University of Leeds and corporate finance at the LondonBusiness School. After an early career in operational management and technicalconsulting, Simon joined the Head Office of Consolidated Gold Fields plc wherehe served in both the Technical and Mining Investment Divisions until thecompany was taken over in 1989. Over the last fifteen years, Simon has workedfor a number of brokers and investment banks in the City, including T Hoare &Co, Evolution Beeson Gregory and Numis Securities, as a mining analystspecialising in small and mid-cap mining companies and as associate director ofthe specialist mining boutique, WCS Limited. Simon will take the position of Commercial Manager at Ovoca Gold with immediateeffect. His role will focus on assisting the Chairman and CEO as Ovoca makes thetransition from a junior explorer to a developer and producer. Ovoca Gold Chairman Roger Turner said "I am pleased we can further strengthenour management with Simon's vast mining experience. His breadth of knowledgeand financial background in particular will further enhance the skills of ourexisting team." Ovoca Gold Plc is an international exploration company with dual listing inLondon (OVG.L) and Dublin (OVX.IR), exploring for precious and base metals inRussia, Sweden and Ireland For further information please visit www.ovocagold.com or contact: Dr Barrie Oakes, CEO - Ovoca Gold Plc Roger Turner, Chairman - Ovoca Gold PlcTel: +44 (0)207 397 8151 Tel: +44 (0)207 397 8151Email: barrie.oakes@ovocagold.com Email: roger.turner@ovocagold.com John O'Connor, Secretary - Ovoca Gold Plc Simon Beardsmore, Commercial Manager - Ovoca Gold PlcTel: +353 (0) 1 491 2944 Tel: +44 (0)207 397 8151Email john.oconnor@ovocagold.com Email: simon.beardsmore@ovocagold.com John Frain - Davy Richard Chase- Ambrian (AIM Broker)Tel: +353 (0)1 679 6363 +44 (0)207 776 6461Email: john.frain@davy.ie Email: richard.chase@ambrian.com Nick Bias / Alex Buck - Buck Bias (UK PR) Tom McCormack - Connexions PR (Irish PR)Tel: +44 (0)7887 920 530 / +44 (0)7932 740 452 Tel: +353 (0)1 230 3015Email: nick@buckbias.com / alex@buckbias.com Email: tom.mcc@indigo.ie This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
29th Jul 20227:00 amRNSCompletion of Enrollment in Phase II Study
30th Jun 20227:00 amRNSAnnual Financial Report
7th Mar 20229:00 amRNSStatement re Russian Business Operations
23rd Feb 20224:41 pmRNSSecond Price Monitoring Extn
23rd Feb 20224:36 pmRNSPrice Monitoring Extension
22nd Feb 20223:30 pmRNSRussian Marketing Authorisation for Orenetide
31st Jan 20227:00 amRNSBoard Changes and Update
30th Dec 20217:00 amRNSDirectorate Change
4th Nov 20213:53 pmRNSHolding(s) in Company
4th Nov 20213:50 pmRNSDirector/PDMR Shareholding
4th Nov 20213:46 pmRNSBoard Change
14th Sep 20217:00 amRNSInterim Results
29th Jul 20215:00 pmRNSResult of AGM
24th Jun 20217:00 amRNSAnnual Report and Notice of AGM
10th Mar 20217:00 amRNSMigration of Participating Securities
16th Feb 20212:00 pmRNSResult of EGM
29th Jan 20217:00 amRNSFirst Patient Enrolled in Phase II Study - BP-101
25th Jan 20213:30 pmRNSNotice of EGM
5th Jan 20217:00 amRNSRe-Filing of Marketing Authorisation Application
17th Dec 20202:45 pmRNSResult of AGM
27th Nov 20203:08 pmRNSNotice of AGM
9th Oct 20207:00 amRNSAppointment of Chief Business Officer
2nd Oct 202011:06 amRNSSecond Price Monitoring Extn
2nd Oct 202011:00 amRNSPrice Monitoring Extension
2nd Oct 20209:05 amRNSSecond Price Monitoring Extn
2nd Oct 20209:00 amRNSPrice Monitoring Extension
2nd Oct 20207:00 amRNSUpdate re Russian Marketing Authorisation
28th Sep 20207:00 amRNSDeath of a Director
21st Sep 20207:00 amRNSInterim Results
14th Aug 202011:05 amRNSSecond Price Monitoring Extn
14th Aug 202011:00 amRNSPrice Monitoring Extension
26th Jun 20207:00 amRNSAnnual Report
14th Apr 20202:05 pmRNSSecond Price Monitoring Extn
14th Apr 20202:00 pmRNSPrice Monitoring Extension
24th Mar 20207:00 amRNSAcquisition of Remaining Minority Interest in IVIX
7th Nov 201912:45 pmRNSAttendance at Bio-Europe Conference
16th Sep 20197:00 amRNSInterim Results
12th Sep 20197:00 amRNSFiling of Marketing Authorisation Application
28th Aug 20197:00 amRNSDirectorate Change
8th Aug 20194:14 pmRNSResult of AGM
8th Aug 20199:05 amRNSSecond Price Monitoring Extn
8th Aug 20199:00 amRNSPrice Monitoring Extension
8th Aug 20197:00 amRNSAGM Statement
26th Jul 20197:00 amRNSDirectorate Change
25th Jul 20194:41 pmRNSSecond Price Monitoring Extn
25th Jul 20194:35 pmRNSPrice Monitoring Extension
28th Jun 20197:00 amRNSAnnual Report and Notice of AGM
23rd Apr 20197:00 amRNSUS and EU Clinical Development Plans
29th Mar 20197:00 amRNSDirector/PDMR Shareholding
27th Mar 20197:00 amRNSOperational Update & Additional Investment in IVIX

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.